In our study, we found that miR‐211‐5p was significantly upregulated in CLL, and its overexpression reversed the inhibitory effects of TUSC7 upregulation on CLL progression. This evidence concerns the gene TUSC7 and B-cell chronic lymphocytic leukemia.